The clinical course of neuromyelitis optica (Devic’s syndrome)
Abstract
Objectives: To evaluate the spectrum of neuromyelitis optica (NMO), including characteristics of the index events (optic neuritis [ON]) and myelitis), neuroimaging, CSF, and serologic studies, and to evaluate the long-term course.
Methods: Review of 71 patients with NMO evaluated at the Mayo Clinic between 1950 and 1997.
Results: NMO was either monophasic or relapsing. Patients with a monophasic course (n = 23) usually presented with rapidly sequential index events (median 5 days) with moderate recovery. Most with a relapsing course (n = 48) had an extended interval between index events (median 166 days) followed within 3 years by clusters of severe relapses isolated to the optic nerves and spinal cord. Most relapsing patients developed severe disability in a stepwise manner, and one-third died because of respiratory failure. Features of NMO distinct from “typical” MS included >50 cells/mm3 in CSF (often polymorphonuclear), normal initial brain MRI, and lesions extending over three or more vertebral segments on spinal cord MRI.
Conclusions: Clinical, laboratory, and imaging features generally distinguish neuromyelitis optica from MS. Patients with relapsing optic neuritis and myelitis may have neuromyelitis optica rather than MS. Patients with a relapsing course of neuromyelitis optica have a poor prognosis and frequently develop respiratory failure during attacks of cervical myelitis.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Devic E. Myelite subaigue compliquee de neurite optique. Bull Med 1894;8:1033–1034.
2.
Gault F. De la neuromyelite optique aigue. Lyon:Thesis, 1894.
3.
Devic E. Myelite aigue dorse-lombaire de neurite optique, autopsie. Congress Français Medicine (premiere session, Lyon). 1895;1:434–439.
4.
Goulden C. Optic neuritis and myelitis. Ophthalmic Rev 1914;34:193–209.
5.
Beck GM. A case of diffuse myelitis associated with optic neuritis. Brain 1927;50:687–703.
6.
Stansbury FC. Neuromyelitis optica (Devic’s disease). Presentation of five cases with pathological study and review of the literature. Arch Ophthalmol 1949;42:292–335, 465–501.
7.
Scott GI. Neuromyelitis optica. Am J Ophthalmol 1952;35:755–764.
8.
Mandler RN, Davis LE, Jeffery DR, Kornfeld MK. Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162–168.
9.
O’Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382–387.
10.
Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991;41:657–660.
11.
Allbutt TC. On the ophthalmoscopic signs of spinal disease. Lancet 1870;1:76–78.
12.
Erb W. Ueber das zusammenvorkommen von Neuritis optica und Myelitis subacuta. Arch Psychiatrie Neureu 1880;10:146–157.
13.
McAlpine D. Familial neuromyelitis optica: its occurrence in identical twins. Brain 1938;61:430–448.
14.
Trojano M, Avolio C, Manzari C, et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300–306.
15.
Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995;13:119–146.
16.
Tourtellotte WW, Staugaitis SM, Walsh MJ, et al. The basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol 1985;17:21–27.
17.
Lumsden C. The clinical pathology of multiple sclerosis. Part III. In: McAlpine D, Lumsden C, Acheson ED, eds. Multiple sclerosis: a reappraisal. 2nd ed. London:Churchill Livingstone, 1972:311–621.
18.
Paty DW, Oger JF, Kastrukoff LF, et al. MRI in the diagnosis of multiple sclerosis: prospective comparison of clinical evaluation, EPs, oligoclonal banding and CT. Neurology 1988;38:180–185.
19.
Fazekas F, Offenbacher H, Strasser-Fuchs S. MRI of neuromyelitis optica: evidence for a distinct entity. J Neurol Neurosurg Psychiatry 1994;59:1140–1142.
20.
Tashiro K, Ito K, Marua Y, et al. MR imaging of spinal cord in Devic disease. J Comput Assist Tomogr 1987;11:516–517.
21.
Thielen KR, Miller GM. Multiple sclerosis of the spinal cord: magnetic resonance appearance. J Comput Assist Tomogr 1996;20:434–438.
22.
Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632–2637.
23.
Mandler RN, Ahmed W, Dencoff JE. Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51:1219–1220.
24.
Lefkowitz D, Angelo DN. Neuromyelitis optica with unusual vascular changes. Arch Neurol 1984;41:1103–1105.
25.
Fukuzawa T, Kikuchi S, Sasaki H, et al. Anti-nuclear antibodies and the optic-spinal form of multiple sclerosis. J Neurol 1997;244:483–488.
26.
April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic’s syndrome) in systemic lupus erythematosis: clinicopathological report and review of the literature. Neurology 1976;26:1066–1070.
27.
Kinney EL, Beroff RL, Rao NS, Lay MF. Devic’s syndrome and systemic lupus erythematosis: a case report and review of the literature. Arch Neurol 1979;36:643–644.
28.
Goldman M, Herode A, Borenstein S, Zanen A. Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arch Rheum 1984;27:701–703.
29.
Hogancamp WE, Rodriguez M, Weinshenker BG. The epidemiology of multiple sclerosis. Mayo Clin Proc 1997;72:871–878.
30.
Kuroiwa Y, Igata A, Itahara K, et al. Nationwide survey of multiple sclerosis in Japan. Neurology 1975;25:845–851.
31.
Kuroiwa Y, Hung T-P, Landsborough D, et al. Multiple sclerosis in Asia. Neurology 1977;27:188–192.
32.
Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981;49:253–271.
33.
Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569–574.
Information & Authors
Information
Published In
Copyright
© 1999.
Publication History
Received: September 15, 1998
Accepted: April 24, 1999
Published online: September 1, 1999
Published in print: September 1, 1999
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Frontiers in Neuromyelitis Optica Spectrum Disorders, Physician Assistant Clinics, 10, 1, (85-95), (2025).https://doi.org/10.1016/j.cpha.2024.07.007
- Abnormal dynamic features of spontaneous brain activity and their concordance in neuromyelitis optica spectrum disorder related optic neuritis: A resting-state fMRI study, Brain Research, 1846, (149228), (2025).https://doi.org/10.1016/j.brainres.2024.149228
- Neuromyelitis Optica: A Peek Into the Brain Through the Eyes, Cureus, (2024).https://doi.org/10.7759/cureus.67408
- Neuromyelitis Optica Spectrum Disorders Resembling Wernicke’s Encephalopathy: A Case Report and Review of Literature, Cureus, (2024).https://doi.org/10.7759/cureus.63920
- Acute-Onset Blindness in a Patient Diagnosed With Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD): A Case Report, Cureus, (2024).https://doi.org/10.7759/cureus.61767
- A Comparative Review of Typical and Atypical Optic Neuritis: Advancements in Treatments, Diagnostics, and Prognosis, Cureus, (2024).https://doi.org/10.7759/cureus.56094
- Жаңы аныкталган клиникалык учур оптиконевромиелит (Девик оорусу), Scientific and practical journal Healthcare of Kyrgyzstan, 2, (78-84), (2024).https://doi.org/10.51350/zdravkg2024.2.6.10.78.84
- Correlation of Retinal Nerve Fibre Layer Thickness in Optical Coherence Tomography with Visual Outcome in Optic Neuritis, TNOA Journal of Ophthalmic Science and Research, 62, 2, (180-185), (2024).https://doi.org/10.4103/tjosr.tjosr_51_22
- Monoclonal antibodies in neuro-ophthalmology, Saudi Journal of Ophthalmology, 38, 1, (13-24), (2024).https://doi.org/10.4103/sjopt.sjopt_256_23
- Recurrent flaccid paraparesis due to acquired distal renal tubular acidosis and coexistent Devic’s disease: The “double trouble”, IJEM Case Reports, 2, 2, (67-71), (2024).https://doi.org/10.4103/ijemcr.ijemcr_20_24
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.